Cell Culture Market - North America, Europe, EMEA, APAC : US, Canada, China, Germany, UK - Forecast 2023-2027
| Published: Dec 2022 | Pages: 169 | SKU: IRTNTR43559 |
Global Cell Culture Market Forecast 2023-2027
The Global Cell Culture Market size is estimated to grow by USD 17.74 billion at a compound annual growth rate (CAGR) of 11.3% between 2022 and 2027. The Global Cell Culture Market plays a pivotal role in advancing biopharmaceutical production. Biopharmaceuticals, sourced from biological entities like vaccines, stem cells, gene therapies, and antibodies, are crucial in modern medicine. Stem cell-based regenerative medicine offers promising solutions for severe chronic ailments. As demand rises, especially for mammalian cell-derived products, biopharmaceutical companies are advancing production technologies like cell culture to meet market needs. Notably, the development of monoclonal antibodies like Humira and Rituxan highlights the efficacy of these advancements, driving growth in the market. This market research and report includes key drivers, trends, and challenges during the forecasted period.
To learn more about this report, Request Free Sample PDF
Market Segmentation
The market share growth by the consumables segment will be significant during the forecast period. The consumables used in cell culture include sera, media, and reagents.
Get a glance at the market contribution of various segments Request Free Sample PDF
The consumables segment was valued at USD 8.03 billion in 2017 and continued to grow until 2021. The consumables segment is the largest revenue-generating segment in the global market because of high availability and vast applicability, and repeated usage. Another major reason for its high adoption is the low price of such products. The rise in the number of diseases among the huge population is triggering market growth as the demand is increasing. Companies are increasing investments in R&D due to the growing cell-based research and the rising demand for cell-based therapies to develop cell media, reagents, and supplements. Therefore, because of the above-mentioned reasons, there will be a rise in this segment during the forecast period.
Regional Analysis
For more insights on the market share of various regions Request Free Sample PDF!
North America is estimated to contribute 39% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
The major factor that is accelerating the growth of the regional market is the presence of important companies such as Thermo Fisher Scientific. These companies are increasingly investing in new manufacturing facilities, which are highly equipped with the required bioprocessing units, and other necessary equipment required for cell culture. Furthermore, companies headquartered in other regions have been investing in the US to establish production sites. This will drive the regional market during the forecast period.
Research on stem cells and cancer is likely to propel the market growth due to an increase in the number of cancer cases. The increasing number of cancer cases is likely to trigger the need for cell-based therapies and vaccines. Additionally, the presence of sophisticated healthcare manufacturing facilities is likely to fuel demand. This will increase the product offerings by the companies and their visibility in the region, which in turn will increase the demand.
Market Dynamics and Customer Landscape
Advanced therapy medicinal products and viral vaccine production heavily rely on cell culture techniques, utilizing three-dimensional cell culture techniques and organoids in bioreactors, including Single-use bioreactors (SUBs), to meet the demands of biopharmaceutical development, enhancing vaccine production and drug discovery efforts while mitigating cross-contamination risk. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Key Market Driver
The market's expansion is driven by the significant potential in emerging regions, particularly India, China, and South Africa, where rapid growth in pharmaceutical and biotechnology infrastructure supports the development of advanced cell culture techniques and substrates for producing viral vaccines and advanced therapy medicinal products. Manufacturers are expanding production facilities in these regions to meet the demand for vaccine production and biopharmaceutical development, leveraging technologies such as three-dimensional cell culture techniques and bioreactors.
For instance, Thermo Fisher Scientific is actively pursuing opportunities in emerging markets like China and India to boost revenue, promoting the adoption of cell-based models and organoids for drug discovery efforts. These initiatives aim to address contagious virus outbreaks and enhance therapeutic and diagnostic tools, thus mitigating cross-contamination risks and meeting operating volume requirements in both single-use and multiple-use bioreactors.
SIgnificant Market Trends
A notable trend in the market is the increasing demand for monoclonal antibodies, which are identical immune cells. These antibodies have diverse applications in fields like biology, diagnostics, and medicine, addressing conditions such as cancer, multiple sclerosis, and cardiovascular disease. The rising demand for monoclonal antibodies is spurring the development of advanced production technologies.
With the prevalence of chronic diseases, the need for antibody treatments is on the rise. Leading manufacturers like Thermo Fisher Scientific are expanding their production facilities with multiple bioreactors. Thermo Fisher Scientific utilizes cutting-edge platforms, single-use methods, and rapid contamination tests for antibody production. This growing demand for monoclonal antibodies is expected to drive the market size by increasing the need for equipment and consumables.
Major Market Challenge
The market faces a significant challenge due to the expensive nature of equipment, which comprises two key segments: consumables and equipment. In comparison, consumables are more cost-effective, while equipment, including CO2 incubators, bioreactors, cryostorage systems, and biosafety cabinets, entails substantial expenses. For example, a cryostorage freezer system for cell banking costs approximately USD 25,000, and a biosafety cabinet exceeds USD 9,000 in cost.
Equipment like CO2 incubators demands frequent cleaning after each incubation batch or procedure to prevent chamber contamination, which can adversely affect subsequent processes. These precision devices require meticulous attention, stable environmental conditions, and regular component maintenance, collectively increasing the total ownership costs. The high acquisition and maintenance costs may deter adoption rates, negatively impacting market growth in the forecasted period.
Key Customer Landscape
The market growth analysis report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market research and growth report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Customer Landscape
Who are the Major Cell Culture Market Companies?
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
FUJIFILM Holdings Corp - The company's key offerings include?cell culture.
The cell culture market growth and analysis report also includes detailed analyses of the competitive landscape of the market and information about 15 market Companies, including:
- Agilent Technologies Inc.
- Avantor Inc.
- Becton Dickinson and Co.
- Bio Techne Corp.
- CLS Cell Lines Service GmbH
- Corning Inc.
- Danaher Corp.
- Eppendorf AG
- General Electric Co.
- InvivoGen
- LABGENE Scientific SA
- Lonza Group Ltd.
- Merck KGaA
- Miltenyi Biotec B.V. & Co. KG
- PromoCell GmbH
Qualitative and quantitative analysis of Companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize Companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize Companies as dominant, leading, strong, tentative, and weak.
Market Analyst Overview
The global cell culture market is witnessing exponential growth driven by advancements in cell culture techniques and substrates, particularly in biopharmaceutical development and vaccine production. With a focus on advanced therapy medicinal products and three-dimensional cell culture techniques, researchers harness cell-based models and organoids to develop therapeutic and diagnostic tools for various applications. High-throughput screening platforms accelerate drug discovery efforts, especially in emerging and established players like Captivate Bio. Notably, the market is witnessing a surge in cell culture-based vaccine production, targeting contagious viruses such as polio, rotavirus, and influenza, as well as emerging pandemics.
European countries are leading in the biopharmaceutical production application segment, with mammalian cell lines like Chinese hamster ovary cells playing a vital role. Single-use bioprocessing systems are gaining traction due to their operational efficiency and reduced cross-contamination risk, particularly in biopharmaceutical manufacturing and vaccine production. However, environmental concerns regarding plastic waste disposal are prompting the adoption of recycling initiatives to mitigate the environmental impact of cell culture consumables.
The market is pivotal in various medical and research applications, ranging from viral vaccines to artificial organs. With the advent of cell culture tools and 3D cell cultures, researchers can develop functional tissues and organs for patients suffering from organ failure. Notable advancements include cell-based flu vaccines and personalized therapy, revolutionizing treatment approaches. Biopharmaceutical manufacturers leverage Single-use bioreactors (SUBs) and Single-use technologies (SUTs) for efficient production, benefiting from operating volume requirements and manufacturing cost advantages. Regulatory guidelines ensure quality and safety in the biopharmaceutical sector, while materials like Polyethylene (PE) and Polypropylene (PP) minimize waste in cell culture processes. As the market expands, emphasis on toxicology and alternative medicines drives innovation for improved patient outcomes.
Segment Overview
The market forecasting report forecasts market growth by revenue at global, regional, and country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
- Product Outlook (USD Billion, 2017 - 2027)
- Consumables
- Equipment
- End-user Outlook (USD Billion, 2017 - 2027)
- Pharma and biotech companies
- Hospitals
- Research and Academic Institutes
- Others
- Region Outlook (USD Billion, 2017 - 2027)
- North America
- The U.S.
- Canada
- Europe
- The U.K.
- Germany
- France
- Rest of Europe
- Asia
- China
- India
- Thailand
- Vietnam
- Others
- Rest of World
- Saudi Arabia
- South Africa
- Brazil
- Chile
- Others
- North America
|
Cell Culture Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
169 |
|
Base year |
2022 |
|
Historic period |
2017-2021 |
|
Forecast period |
2023-2027 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 11.3% |
|
Market growth 2023-2027 |
USD 17.74 billion |
|
Market structure |
Fragmented |
|
YoY growth 2022-2023(%) |
10.61 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 39% |
|
Key countries |
US, Germany, UK, China, and Japan |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Agilent Technologies Inc., Avantor Inc., Becton Dickinson and Co., Bio Techne Corp., CLS Cell Lines Service GmbH, Corning Inc., Danaher Corp., Eppendorf AG, FUJIFILM Holdings Corp, General Electric Co., InvivoGen, LABGENE Scientific SA, Lonza Group Ltd., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, PromoCell GmbH, Sartorius AG, Sartorius CellGenix GmbH, Thermo Fisher Scientific Inc., and ZenBio Inc. |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Request Market Research Report Sample PDF
What are the Key Data Covered in this Market Report?
- CAGR of the market forecast
- Detailed information on factors that will drive the market growth and forecasting between 2023 and 2027
- Precise estimation of the market size and its contribution to the parent market
- Accurate predictions about upcoming trends and changes in consumer behavior
- Growth of the industry across North America, Europe, Asia, and Rest of World (ROW)
- A thorough analysis of the market’s competitive landscape and detailed information about Companies
- Comprehensive analysis of factors that will challenge the growth of market companies
We can help! Our analysts can customize this market report to meet your requirements. Get in touch
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 13: Market segments
- 3.3 Market size 2022
- 3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
- Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
- 4.1 Global cell culture market 2017 - 2021
- Exhibit 18: Historic Market Size – Data Table on Global cell culture market 2017 - 2021 ($ billion)
- 4.2 Product Segment Analysis 2017 - 2021
- Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ billion)
- 4.3 End-user Segment Analysis 2017 - 2021
- Exhibit 20: Historic Market Size – End-user Segment 2017 - 2021 ($ billion)
- 4.4 Geography Segment Analysis 2017 - 2021
- Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ billion)
- 4.5 Country Segment Analysis 2017 - 2021
- Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ billion)
5 Five Forces Analysis
- 5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
- 5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
- 5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
- 5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
- 5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
- 5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
- 5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Product
- 6.1 Market segments
- Exhibit 30: Chart on Product - Market share 2022-2027 (%)
- Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
- 6.2 Comparison by Product
- Exhibit 32: Chart on Comparison by Product
- Exhibit 33: Data Table on Comparison by Product
- 6.3 Consumables - Market size and forecast 2022-2027
- Exhibit 34: Chart on Consumables - Market size and forecast 2022-2027 ($ billion)
- Exhibit 35: Data Table on Consumables - Market size and forecast 2022-2027 ($ billion)
- Exhibit 36: Chart on Consumables - Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on Consumables - Year-over-year growth 2022-2027 (%)
- 6.4 Equipment - Market size and forecast 2022-2027
- Exhibit 38: Chart on Equipment - Market size and forecast 2022-2027 ($ billion)
- Exhibit 39: Data Table on Equipment - Market size and forecast 2022-2027 ($ billion)
- Exhibit 40: Chart on Equipment - Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on Equipment - Year-over-year growth 2022-2027 (%)
- 6.5 Market opportunity by Product
- Exhibit 42: Market opportunity by Product ($ billion)
7 Market Segmentation by End-user
- 7.1 Market segments
- Exhibit 43: Chart on End-user - Market share 2022-2027 (%)
- Exhibit 44: Data Table on End-user - Market share 2022-2027 (%)
- 7.2 Comparison by End-user
- Exhibit 45: Chart on Comparison by End-user
- Exhibit 46: Data Table on Comparison by End-user
- 7.3 Pharma and biotech companies - Market size and forecast 2022-2027
- Exhibit 47: Chart on Pharma and biotech companies - Market size and forecast 2022-2027 ($ billion)
- Exhibit 48: Data Table on Pharma and biotech companies - Market size and forecast 2022-2027 ($ billion)
- Exhibit 49: Chart on Pharma and biotech companies - Year-over-year growth 2022-2027 (%)
- Exhibit 50: Data Table on Pharma and biotech companies - Year-over-year growth 2022-2027 (%)
- 7.4 Hospitals - Market size and forecast 2022-2027
- Exhibit 51: Chart on Hospitals - Market size and forecast 2022-2027 ($ billion)
- Exhibit 52: Data Table on Hospitals - Market size and forecast 2022-2027 ($ billion)
- Exhibit 53: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
- Exhibit 54: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
- 7.5 Research and academic Institutes - Market size and forecast 2022-2027
- Exhibit 55: Chart on Research and academic Institutes - Market size and forecast 2022-2027 ($ billion)
- Exhibit 56: Data Table on Research and academic Institutes - Market size and forecast 2022-2027 ($ billion)
- Exhibit 57: Chart on Research and academic Institutes - Year-over-year growth 2022-2027 (%)
- Exhibit 58: Data Table on Research and academic Institutes - Year-over-year growth 2022-2027 (%)
- 7.6 Others - Market size and forecast 2022-2027
- Exhibit 59: Chart on Others - Market size and forecast 2022-2027 ($ billion)
- Exhibit 60: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
- Exhibit 61: Chart on Others - Year-over-year growth 2022-2027 (%)
- Exhibit 62: Data Table on Others - Year-over-year growth 2022-2027 (%)
- 7.7 Market opportunity by End-user
- Exhibit 63: Market opportunity by End-user ($ billion)
8 Customer Landscape
- 8.1 Customer landscape overview
- Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Exhibit 65: Chart on Market share by geography 2022-2027 (%)
- Exhibit 66: Data Table on Market share by geography 2022-2027 (%)
- 9.2 Geographic comparison
- Exhibit 67: Chart on Geographic comparison
- Exhibit 68: Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2022-2027
- Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ billion)
- Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
- Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
- 9.4 Europe - Market size and forecast 2022-2027
- Exhibit 73: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
- Exhibit 74: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
- Exhibit 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
- 9.5 Asia - Market size and forecast 2022-2027
- Exhibit 77: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
- Exhibit 78: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
- Exhibit 79: Chart on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 80: Data Table on Asia - Year-over-year growth 2022-2027 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
- Exhibit 81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
- Exhibit 82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
- Exhibit 83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- 9.7 US - Market size and forecast 2022-2027
- Exhibit 85: Chart on US - Market size and forecast 2022-2027 ($ billion)
- Exhibit 86: Data Table on US - Market size and forecast 2022-2027 ($ billion)
- Exhibit 87: Chart on US - Year-over-year growth 2022-2027 (%)
- Exhibit 88: Data Table on US - Year-over-year growth 2022-2027 (%)
- 9.8 China - Market size and forecast 2022-2027
- Exhibit 89: Chart on China - Market size and forecast 2022-2027 ($ billion)
- Exhibit 90: Data Table on China - Market size and forecast 2022-2027 ($ billion)
- Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)
- Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)
- 9.9 Germany - Market size and forecast 2022-2027
- Exhibit 93: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
- Exhibit 94: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
- Exhibit 95: Chart on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
- 9.10 Japan - Market size and forecast 2022-2027
- Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
- Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
- Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
- Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
- 9.11 UK - Market size and forecast 2022-2027
- Exhibit 101: Chart on UK - Market size and forecast 2022-2027 ($ billion)
- Exhibit 102: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
- Exhibit 103: Chart on UK - Year-over-year growth 2022-2027 (%)
- Exhibit 104: Data Table on UK - Year-over-year growth 2022-2027 (%)
- 9.12 Market opportunity by geography
- Exhibit 105: Market opportunity by geography ($ billion)
10 Drivers, Challenges, and Trends
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Exhibit 106: Impact of drivers and challenges in 2022 and 2027
- 10.4 Market trends
11 Vendor Landscape
- 11.1 Overview
- 11.2 Vendor landscape
- Exhibit 107: Overview on Criticality of inputs and Factors of differentiation
- 11.3 Landscape disruption
- Exhibit 108: Overview on factors of disruption
- 11.4 Industry risks
- Exhibit 109: Impact of key risks on business
12 Vendor Analysis
- 12.1 Vendors covered
- Exhibit 110: Vendors covered
- 12.2 Market positioning of vendors
- Exhibit 111: Matrix on vendor position and classification
- 12.3 Agilent Technologies Inc.
- Exhibit 112: Agilent Technologies Inc. - Overview
- Exhibit 113: Agilent Technologies Inc. - Business segments
- Exhibit 114: Agilent Technologies Inc. - Key news
- Exhibit 115: Agilent Technologies Inc. - Key offerings
- Exhibit 116: Agilent Technologies Inc. - Segment focus
- 12.4 Becton Dickinson and Co.
- Exhibit 117: Becton Dickinson and Co. - Overview
- Exhibit 118: Becton Dickinson and Co. - Business segments
- Exhibit 119: Becton Dickinson and Co. - Key news
- Exhibit 120: Becton Dickinson and Co. - Key offerings
- Exhibit 121: Becton Dickinson and Co. - Segment focus
- 12.5 Bio Techne Corp.
- Exhibit 122: Bio Techne Corp. - Overview
- Exhibit 123: Bio Techne Corp. - Business segments
- Exhibit 124: Bio Techne Corp. - Key news
- Exhibit 125: Bio Techne Corp. - Key offerings
- Exhibit 126: Bio Techne Corp. - Segment focus
- 12.6 CLS Cell Lines Service GmbH
- Exhibit 127: CLS Cell Lines Service GmbH - Overview
- Exhibit 128: CLS Cell Lines Service GmbH - Product / Service
- Exhibit 129: CLS Cell Lines Service GmbH - Key offerings
- 12.7 Corning Inc.
- Exhibit 130: Corning Inc. - Overview
- Exhibit 131: Corning Inc. - Business segments
- Exhibit 132: Corning Inc. - Key news
- Exhibit 133: Corning Inc. - Key offerings
- Exhibit 134: Corning Inc. - Segment focus
- 12.8 Danaher Corp.
- Exhibit 135: Danaher Corp. - Overview
- Exhibit 136: Danaher Corp. - Business segments
- Exhibit 137: Danaher Corp. - Key news
- Exhibit 138: Danaher Corp. - Key offerings
- Exhibit 139: Danaher Corp. - Segment focus
- 12.9 Eppendorf AG
- Exhibit 140: Eppendorf AG - Overview
- Exhibit 141: Eppendorf AG - Product / Service
- Exhibit 142: Eppendorf AG - Key news
- Exhibit 143: Eppendorf AG - Key offerings
- 12.10 FUJIFILM Holdings Corp
- Exhibit 144: FUJIFILM Holdings Corp - Overview
- Exhibit 145: FUJIFILM Holdings Corp - Business segments
- Exhibit 146: FUJIFILM Holdings Corp - Key offerings
- Exhibit 147: FUJIFILM Holdings Corp - Segment focus
- 12.11 General Electric Co.
- Exhibit 148: General Electric Co. - Overview
- Exhibit 149: General Electric Co. - Business segments
- Exhibit 150: General Electric Co. - Key news
- Exhibit 151: General Electric Co. - Key offerings
- Exhibit 152: General Electric Co. - Segment focus
- 12.12 InvivoGen
- Exhibit 153: InvivoGen - Overview
- Exhibit 154: InvivoGen - Product / Service
- Exhibit 155: InvivoGen - Key offerings
- 12.13 LABGENE Scientific SA
- Exhibit 156: LABGENE Scientific SA - Overview
- Exhibit 157: LABGENE Scientific SA - Product / Service
- Exhibit 158: LABGENE Scientific SA - Key offerings
- 12.14 Lonza Group Ltd.
- Exhibit 159: Lonza Group Ltd. - Overview
- Exhibit 160: Lonza Group Ltd. - Business segments
- Exhibit 161: Lonza Group Ltd. - Key news
- Exhibit 162: Lonza Group Ltd. - Key offerings
- Exhibit 163: Lonza Group Ltd. - Segment focus
- 12.15 Merck KGaA
- Exhibit 164: Merck KGaA - Overview
- Exhibit 165: Merck KGaA - Business segments
- Exhibit 166: Merck KGaA - Key news
- Exhibit 167: Merck KGaA - Key offerings
- Exhibit 168: Merck KGaA - Segment focus
- 12.16 Sartorius CellGenix GmbH
- Exhibit 169: Sartorius CellGenix GmbH - Overview
- Exhibit 170: Sartorius CellGenix GmbH - Product / Service
- Exhibit 171: Sartorius CellGenix GmbH - Key news
- Exhibit 172: Sartorius CellGenix GmbH - Key offerings
- 12.17 Thermo Fisher Scientific Inc.
- Exhibit 173: Thermo Fisher Scientific Inc. - Overview
- Exhibit 174: Thermo Fisher Scientific Inc. - Business segments
- Exhibit 175: Thermo Fisher Scientific Inc. - Key news
- Exhibit 176: Thermo Fisher Scientific Inc. - Key offerings
- Exhibit 177: Thermo Fisher Scientific Inc. - Segment focus
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Exhibit 178: Inclusions checklist
- Exhibit 179: Exclusions checklist
- 13.3 Currency conversion rates for US$
- Exhibit 180: Currency conversion rates for US$
- 13.4 Research methodology
- Exhibit 181: Research methodology
- Exhibit 182: Validation techniques employed for market sizing
- Exhibit 183: Information sources
- 13.5 List of abbreviations
- Exhibit 184: List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
PURCHASE FULL REPORT OF
cell culture market
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
- Off-the-shelf research reports
- Reports can be tailored to meet the customer's needs
- Trusted by more than 100 fortune 500 organizations
- Information about the market's key drivers, trends, and challenges
- Parent market analysis
- Every week, 50,000 people visit our subscription platform
- Detailed vendors report with competitive landscape
- Covid-19 impact and recovery analysis
- Data on revenue-generating market segments
- Details on the market shares of various regions
- Five-force market analysis